The global tinea pedis treatment market to grow at a CAGR of 3.03% during the period 2017-2021.
This report, Global Tinea Pedis Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.
According to the report, one of the major drivers for this market is high unmet needs. The global tinea pedis treatment market faces significant unmet needs due to low treatment efficacy and prolonged treatment duration. Certain drugs show their efficacy only in the treatment of mild cases of infection. Also, the infection continues to recur as the treatment does not completely cure it. Multiple cycles of unsuccessful treatments increase patient discomfort. This creates a large gap between the demand for and supply of these therapeutics. Thus, the market provides a growth opportunity for vendors with the increasing demand for effective pharmacological therapeutics for fungal infections.
- Exeltis USA
- Viamet Pharmaceuticals
Other prominent vendors:
- Aqua Pharmaceuticals
- Bristol-Myers Squibb
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Pipeline landscape
Part 06: Market landscape
Part 07: Market segmentation by ROA
Part 08: Market segmentation by disease type
Part 09: Geographical segmentation
Part 10: Decision framework
Part 11: Drivers and challenges
Part 12: Market trends
Part 13: Vendor landscape
Part 14: Key vendor analysis
For more information about this report visit https://www.researchandmarkets.com/research/4mtzg7/global_tinea